Compare Petróleo Brasileiro SA (PBR) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Petróleo Brasileiro SA vs Summit Therapeutics Inc — how do they compare? Petróleo Brasileiro SA trades at $19 (market cap $112.59B), while Summit Therapeutics Inc trades at $14.78 (market cap $11.34B). The key difference: Petróleo Brasileiro SA is far larger — about 9.9× Summit Therapeutics Inc's market cap, and Petróleo Brasileiro SA pays a 9.51% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| PBR | SMMT | |
|---|---|---|
Market Cap | $112.59B | $11.34B |
Sector | Technology | Health |
52-Week High | $22.03 | $29.32 |
52-Week Low | $11.54 | $13.05 |
Enterprise Value | $176.05B | $10.76B |
Dividend Yield | 9.51% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Petróleo Brasileiro SA
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
